IM erythropoietin + IV iron sucrose vs IV iron sucrose + IM placebo
Serious adverse events ‐ disease activity not stated (12 weeks) · IBD patients
1 finding from 1 review
- Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 40 participantsVery low